This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $32,647.38 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 31, 2024. The contract has an ultimate completion date of November 1, 2024 and is not designated as a set-aside.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is likely a part of this broader IDC. AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Generated 1/30/25, 9:29 AM